Apricus Biosciences (APRI -5%) trades lower this morning after admitting it made misleading...

|About: Apricus Biosciences, Inc (APRI)|By:, SA News Editor

Apricus Biosciences (APRI -5%) trades lower this morning after admitting it made misleading statements by citing FDA "approval" for three of its new OTC drugs when it should have said they were "compliant."